Premier Perspectives Blog

The blog for insider insights in clinical development

PREMIER VOICES #15

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19

PREMIER VOICES #10

COVID-19 Update – How the FDA’s Emergency Use Authorization Can Help Develop Therapies Faster

PREMIER VOICES #15

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19

PREMIER VOICES #10

COVID-19 Update – How the FDA’s Emergency Use Authorization Can Help Develop Therapies Faster

Cell & Gene Therapy

Rethinking Long-Term Follow-Up: How Decentralized Models Improve Retention, Reduce Burden, and Maintain Data Quality

Featured Posts

Cell & Gene Therapy

Expanding Access and Capacity in Cell and Gene Therapy Clinical Trials: Addressing a Shifting Landscape

Choosing the Right PK Modeling Approach: Utilizing NCA, PopPK/PD, and PBPK Tools for MIDD Success

Recent Posts